VISTAGEN THERAPEUTICS, INC. Accumulated Other Comprehensive Income
VISTAGEN THERAPEUTICS, INC. (VTGN) had Accumulated Other Comprehensive Income of -$7.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax · last filed 2026-08-14
- 2026-06-30: Accumulated Other Comprehensive Income (Loss), Net of Tax -$7.00K.
- 2026-03-31: Accumulated Other Comprehensive Income (Loss), Net of Tax -$2.00K.
- 2025-12-31: Accumulated Other Comprehensive Income (Loss), Net of Tax $13.00K.
- 2025-09-30: Accumulated Other Comprehensive Income (Loss), Net of Tax $14.00K.
| Period end | Accumulated Other Comprehensive Income (Loss), Net of Tax |
|---|---|
| 2026-06-30 | -$7.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | -$2.00K 10-Q · filed 2026-08-14 |
| 2025-12-31 | $13.00K 10-Q · filed 2026-02-12 |
| 2025-09-30 | $14.00K 10-Q · filed 2025-11-13 |
| 2025-06-30 | $1.00K 10-Q · filed 2025-08-07 |
| 2025-03-31 | $5.00K 10-K · filed 2026-06-15 |
| 2024-12-31 | $11.00K 10-Q · filed 2025-02-13 |
| 2024-09-30 | $22.00K 10-Q · filed 2024-11-07 |
| 2024-06-30 | $2.00K 10-Q · filed 2024-08-13 |
| 2024-03-31 | $0.00 10-K · filed 2025-06-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |